Results 1 to 10 of about 1,862,216 (244)

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation. [PDF]

Clin Pharmacol Ther
Park HW, Lee JH, Jeong JO, Gorog DA, Tantry US, Kim BK, Joo HJ, Chang K, Hwang JY, Song YB, Ahn SG, Suh JW, Choi WG, Cho JR, Kang J, Lee SY, Kim HS, Kim MH, Lim DS, Shin ES, Gurbel PA, Jeong YH, PTRG‐DES Consortium Investigators.   +22 more
europepmc   +1 more source

Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent. [PDF]

J Cardiovasc Transl Res
Wild L, Beele A, Seguchi M, Lenz T, Nicol P, Sabic-Halilcevic E, Klosterman GR, Kastrati A, Joner M.   +8 more
europepmc   +1 more source

Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report. [PDF]

AME Case Rep
Lin KK, Wine YY, Aye ST.
europepmc   +1 more source

Long-Term Efficacy of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent for De Novo Large-Vessel Coronary Arteries. [PDF]

Circ Rep
Masuda M, Yamamoto H, Nakano S, Takahashi N, Miyata T, Inoue T, Takaya T.   +6 more
europepmc   +1 more source

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions. [PDF]

Catheter Cardiovasc Interv
Corballis N, Merinopoulos I, Bhalraam U, Gunawardena T, Tsampasian V, Natarajan R, Wickramarachchi U, Mohamed M, Clark A, Mamas MA, Vassiliou VS, Eccleshall S, SPARTAN‐Norfolk Consortium.   +12 more
europepmc   +1 more source

Comparative Evaluation of Incidence of Cardiovascular Events Among Different Drug-Eluting Stent Features: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Koushki H, Vafa RG, Heydarzadeh R, Zarifkar H, Hosseini AK, Zarifkar H, Zarifkar H, Azadian A, Amiri F, Mohammadhassani A, Montaseri M, Hosseini N, Sadeghi M, Hosseini SA, Mirhosseini SA, Kojuri J.   +15 more
europepmc   +1 more source

A case of progressive giant coronary aneurysm following first-generation drug-eluting stent implantation for chronic total occlusion-a case report and literature review. [PDF]

Front Cardiovasc Med
Li B, Han S, Li Z, Jin Q.
europepmc   +1 more source

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis. [PDF]

Clin Res Cardiol
Krefting J, Krüger N, Friess C, Gräßer C, Schmieder R, Starnecker F, Schwab M, Kufner S, Trenkwalder T, Voll F, Sager HB, Kessler T, Xhepa E, Offenborn F, Dreischulte T, Giacoppo D, Cassese S, Kastrati A, Schunkert H, von Scheidt M, Wiebe J.   +20 more
europepmc   +1 more source

Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus. [PDF]

Cardiovasc Diabetol
Gitto M, Filiberti G, Leone PP, Chiarito M, Gurgoglione FL, Tartaglia F, Frazzetto M, Calamita G, Rossi ML, Bernardini V, Reimers B, Regazzoli D, Mangieri A, Gasparini G, Briguori C, Latib A, Stefanini GG, Godino C, Sardella G, Cortese B, Colombo A.   +20 more
europepmc   +1 more source

Percutaneous Treatment of a Giant Coronary Artery Aneurysm Using a Covered Stent With a Drug-Eluting Stent "Sandwich" Technique: A Case Report. [PDF]

Cureus
Umashankar A, Ali MH, Abdelmaaboud M, Ionescu A.   +3 more
europepmc   +1 more source